
Sucralose changes the gut microbiome, disrupts T cell activity, and reduces the effectiveness of immunotherapy. Sucralose is a widely used artificial sweetener for people aiming to cut calories or control blood sugar, but new research from the University of Pittsburgh and UPMC Hillman Cancer Center indicates it may not be suitable for patients receiving cancer [...]